Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 16265 articles
Time-dependent impact of programmed death-ligand 1 expression on early progression and long-term response to first-line osimertinib in epidermal growth factor receptor-mutant non-small cell lung cancer.
Beyond 12 months, PD-L1 impact no longer evident.
»
01/23/26
Outcomes of long-term responders to immunotherapy in the treatment of advanced non-small cell lung cancer (NSCLC). A retrospective regional study.
Data support treatment cessation for patients with controlled disease after two years of ICI.
»
05/06/26
Transcriptomic immune subtyping and connectivity mapping nominate DNA methyltransferase inhibitors for immunedepleted melanoma.
All four DNMT inhibitors retained above-median ranks.
»
07/19/26
Cross-Cohort Characterization of an LHB-Associated Transcriptomic State in Prostate Cancer.
Sample-level single-cell contrasts showed lower androgen receptor signaling.
»
08/21/26
Randomized Prospective Comparison Between Neoadjuvant Mitomycin C Plus Cisplatin and Paclitaxel Plus Carboplatin in Patients With BRCA1-Associated Ovarian Cancer.
No differences in progression-free survival or DFI between treatment arms.
»
08/31/26
PAX9 activates autophagy through a transcription-dependent mechanism, promoting EGFR degradation to restrict cell survival in oral cancer.
Overexpression of PAX9 activated autophagy and enhanced lysosomal function.
»
12/18/25
Impact of Smoking on Treatment Outcomes in Patients With Human Papillomavirus-Related Oropharyngeal Cancer.
Smoking associated with worse PFS.
»
04/09/26
Active Surveillance in Papillary Thyroid Cancer With Primary Tumors Greater Than 1.5 cm.
Active surveillance viable initial management option.
»
04/05/26
Prognostic impact of blood group O in MGMT-methylated glioblastoma patients receiving radiochemotherapy with temozolomide and lomustine.
Blood group O associated with longer OS.
»
08/13/26
ECT2 antagonizes lipoic acid to modulate papillary thyroid carcinoma progression through energy metabolism pathways
ECT2 may promote expression of glycolysis-related genes by inducing RhoA phosphorylation.
»
09/10/26
< Prev
Next >